We are Azenta Life Sciences. We provide unrivaled sample exploration and management solutions to help our customers accelerate discovery, development and delivery.
Brooks Life Sciences Services and Products business is rebranded under the creation of a new identity – Azenta Life Sciences. An independent, integrated company dedicated to enabling life sciences organizations to bring impactful breakthroughs and therapies to market faster. Our name, Azenta, signals our commitment to helping customers reach new heights in their pursuit of scientific progress.
We have 3000 employees around the world working across our leading capabilities of genomics, cryostorage, automation and informatics. We continue to build our portfolio to help more and more organizations operate with greater speed and precision.
With us by their side, our customers can:
Rely on industry-leading expertise
We combine the latest technologies with the depth of our expertise—as molecular biologists, automation engineers, data scientists, and more—to advance the work of fellow life sciences leaders throughout the development life cycle.
Find the precise solutions they need
Our customers deal with unique and complex challenges. We build a rich understanding of what they need in order to connect them with the right tools and services in our ever-expanding suite of offerings—today and as their needs evolve.
Act with conviction
Because we refuse to compromise on the quality, compliance, privacy and integrity of samples and data, our customers can make the vital decisions they face quickly and confidently.
At Azenta, we are built to support our customers. To help them move faster and smarter—making a healthier world for people everywhere.
Brooks (Nasdaq: BRKS) operates two global, market-leading businesses, Life Sciences and Semiconductor Solutions, each with its own distinct area of focus and expertise. The Life Sciences business, to be operated under the new Azenta brand, provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. On September 20, 2021, the Company announced the pending sale to Thomas H. Lee Partners of its Semiconductor Solutions Group business, which provides industry-leading precision vacuum robotics, integrated automation systems and contamination control solutions to the world's leading semiconductor chip makers and equipment manufacturers as well as collaborative robotics and automation capabilities for multi-market applications. Brooks is headquartered in Chelmsford, MA, with operations in North America, Europe and Asia. For more information, please visit www.brooks.com.